NCT07788755Not yet recruiting
NEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in Schizophrenia
NEUROmetabolic Mechanisms of COGnitive Training in Schizophrenia
Source: ClinicalTrials.gov · Last updated 3 Nov 2026
Brief summary (registry, in English)
This study will examine brain metabolic and excitatory/inhibitory mechanisms related to cognitive and visual functioning in adults with schizophrenia and healthy control participants. Participants will complete behavioral assessments, cognitive testing, electroencephalography, magnetic resonance imaging, and magnetic resonance spectroscopy assessments. After baseline assessments, participants will be randomly assigned to one of two computerized cognitive training programs: perceptual discrimination training or cognitive control training. Each training program will include approximately 10 hours of training over 2 to 6 weeks. The study will evaluate changes in cognitive and visual task performance, EEG measures, and brain metabolite concentrations before and after cognitive training. Some participants may also complete optional extended baseline assessments before cognitive training.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 168 (estimated)
- First submitted
- 31 Jul 2026
- Start date
- 16 Nov 2026
- Primary completion date
- 1 Jun 2031
- Lead sponsor
- University of Minnesota
- Diseases
- Schizophrenia
- NCT number
- NCT07788755
What you commit to
- Study type: Interventional
- Planned participants: 168
- From 16 Nov 2026 to the primary completion date, 1 Jun 2031
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Medication or substance induced psychosis
Other illness
- Presence of major neurological disorder
- Conditions preventing MR scanning or other MRI contraindications:
- Implanted devices or ferromagnetic objects, current pregnancy (positive pregnancy test on day of MRI scanning or currently breast-feeding), etc. Significant movement disorders including tardive dyskinesia that could disrupt MRI and MRS recordings. Medically significant condition considered unsuitable for the current study (e.g., epilepsy, etc.)
- Other relevant comorbidity (e.g., epilepsy, developmental disability) or visual impairment
- Presence of current substance use disorder (moderate or severe; excluding caffeine and nicotine), as measured by the MINI-7 or SCID 5 based on DSM-5 criteria.
- For healthy controls, additionally:
- Personal or immediate first-degree family history of a psychotic or mood disorder. Specifically, current or past history of meeting DSM-5 criteria for schizophrenia spectrum or other psychotic disorders, or Bipolar I or II Disorder, major depressive disorder, posttraumatic stress disorder, panic disorder, obsessive compulsive disorder, dysthymic disorder. Those with a first or second-degree relative with a current or past history of meeting DSM-5 criteria for schizophrenia or other psychotic disorders or bipolar I or II disorder, because they might have an underlying genetic susceptibility for psychosis symptoms.
- Presence of symptoms of the following DSM-5 disorders (as assessed by the MINI-7 or SCID 5):
- Panic disorder
- Obsessive-Compulsive Disorder
- Posttraumatic Stress Disorder
- Alcohol Use Disorder
- Substance Use Disorder (Non-Alcoholic)
- Psychotic Disorders and Mood Disorders with Psychotic Features
- Major Depressive Disorder (MDD)
- Other Specified Bipolar and Related Disorder
Other
- Estimated IQ \< 70
- Major Depressive Episode
- Suicidality
- Manic and Hypomanic Episodes
- MDD with Psychotic Features
- Bipolar I
- Bipolar II
Who the study is looking for
- All participants (healthy control and SZ):
- Age: 18-79
- Have given written informed consent
- Be able to read and write in English
- General health status: Participants should be in good general physical health (no major neurological disorder or head injury with prolonged unconsciousness, and no current moderate or severe substance use disorder)
- Geographic location: Minnesota counties that are approximately within 1 hour driving distance to Twin Cities, including, but not limited to, Hennepin, Ramsey, Washington, Anoka, Wright, Carver, Scott, Dakota, Sherburn
- Agree to refrain from using recreational drugs for 1 week prior to each scanning session, including, but not limited to, marijuana
- For people with schizophrenia (SZ):
- Current DSM-5 diagnosis of schizophrenia or schizoaffective disorder. Participants should be in stable psychiatric health, evidenced by no suicide attempt or psychiatric hospitalization within the past 1 month. (Initial diagnosis will be assessed using SCID 5 or MINI-7, and confirmation of ongoing SZ status and symptom changes will be monitored at each major timepoint using BPRS.)
- All SZ must have achieved clinical stability, defined as outpatient status for at least one month prior to study participation, plus stable doses of psychiatric medications for at least 1 month prior to study participation (as reported by participants and confirmed via medication list (procured by participants via their own medical or pharmacy records) and/or current pill bottle labels).
- All participants should have symptom ratings below a rating of 7 "extremely severe" on a severity scale of 1-7 on the BPRS and/or below grade 3 on longitudinal assessment defined by (as determined by the PI):
- Grade 1: Worsening of 1 point on any item within each BPRS factor
- Grade 2: Worsening of 2 points on any item within each BPRS factor
- Grade 3: Worsening of 3+ points on any item within each BPRS factor, or a change to a rating of extremely severe
- Grade 4: Suicide attempt with intent to die
Age in the registry: 18 years to 79 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Center for Magnetic Resonance Research, University of Minnesota Coordinator of this site? Confirm its status | Minneapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.